RxDoctor Payments DataLook up a doctor →

Leslie Klaff

Endocrinology, Diabetes & Metabolism · Renton, WANPI 1720009764

Payments from drug & device makers

$2,801,337in general payments, 2019–2025

Across 873 payments — averaging $3208.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2M
  • Roche Diabetes Care, Inc.$200K
  • Pfizer$177K
  • Novo Nordisk AS$156K
  • Ascensia Diabetes Care US Inc.$142K
  • Abbott$77K
  • plus $24K from 4 others
$452,933in research payments, 2019–2025

Across 22 payments — averaging $20,588 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ascensia Diabetes Care US Inc.$292K
  • Eli Lilly$160K
  • Eli Lilly Export S.A. Puerto Rico Branch$790

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,801,337 in reported general payments places this provider in the 95th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.

See all endocrinology, diabetes & metabolism providers in Washington

Other endocrinology, diabetes & metabolism in Renton

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →